As a consequence of distinctive pharmacokinetic profiles, oral formulations usually are not interchangeable with prolonged launch on an mg-mg foundation due to distinctive pharmacokinetic profiles Can be specified as monotherapy or as adjunctive therapy with stimulants. The prolonged-release